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Objectives: The aim of the study was to assess the prognostic value of stress echocardiography after surgical revascularization.
Methods: We evaluated 500 (100 women) patients who had undergone exercise or pharmacological SE after a median of 69 months after
coronary artery by-pass grafting (CABG). Of these, 351 (70%) complained of symptoms suggestive of ischemic origin while 149 (30%) were
tested for asymptomatic progression of the disease.
Results: SE was positive for ischemia in 196 (39%) patients. During a median follow-up of 25 months, 61 patients died, 33 had a nonfatal
myocardial infarction, and 112 underwent late (N3 months) revascularization. Multivariable Cox' regression analysis indicated age
(HR=1.04; 95% CI 1.01–1.06; pb0.003), and peak WMSI (HR=3.07; 95% CI 1.96–4.81; p=0.0001) as independent predictors of hard
(total mortality and myocardial infarction) events. SE information provided a significant improvement in predictive power of the statistical
model (chi-square increase 34%, pb0.0001 for hard and 91%, pb0.0001 for major events, respectively). Survival analysis showed ischemia
at SE to be associated with significantly higher hard and major event rate in both symptomatic and asymptomatic patients.
Discussion: SE represents an effective tool for the risk stratification of patients with previous CABG independently of the presence of
symptoms suggestive of ischemic origin.
© 2009 Elsevier Ireland Ltd. All rights reserved.Keywords: Coronary Artery by-grafting; Coronary artery disease; Stress echocardiography1. Introduction
The need for stress testing after coronary artery bypass
grafting (CABG) is based upon the possible presence of
incomplete revascularization, the development of new
disease in bypass grafts, and/or the progression of native
coronary disease. Present guidelines from the American
College of Cardiology/American Heart Association recom-
mend exercise or pharmacologic stress with imaging using
nuclear scan or echocardiography [1]. This recommendation⁎ Corresponding author. CNR, Institute of Clinical Physiology, Via G.
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(2009), doi:10.1016/j.ijcard.2009.03.063is supported by the lower sensitivity of exercise ECG testing
alone to identify ischemia and the need to document both site
and extent of ischemia after revascularization.
The diagnostic accuracy of stress imaging techniques
following CABG has been evaluated in a number of studies
demonstrating an almost significant trend toward greater
sensitivity of echocardiography compared to radionuclide
perfusion scintigraphy [2]. Less attention, however, has gone
to the assessment of the prognostic value of stress imaging,
in particular with echocardiographic technique. In addition,
physical exercise has been the most used stressing modality,
even though a substantial proportion of post-CABG patients
are unable to achieve adequate levels of exercise. Thus, we
sought to evaluate the prognostic value of exercise orstratification of patients following coronary bypass surgery, Int J Cardiol
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tive series of patients who had undergone previous CABG.
2. Methods
2.1. Study population
From a prospective data bank including 8940 consecutive
subjects with known or suspected coronary artery disease
undergoing SE between 1995 and 2006, we selected 500
patients (100 women) according to the following criteria: 1)
previous CABG, 2) no acute coronary syndromes occurring
after the index CABG, 3) no significant valvular and/or
congenital heart disease, 4) no prognostically relevant co-
morbidities, 5) adequate acoustic window. Patients had
undergone SE at a median time of 69±24 months following
CABG. Reasons for testing were the presence of symptoms
suggestive of ischemic origin in 351 (70%) and screening for
asymptomatic progression of the disease in 149 (30%)
patients.
Informed consent was obtained from all patients before
testing, and the study protocol was approved by the
institutional ethical committee. Stress echo data were
collected and analysed by stress echocardiographers not
involved in patient care.
The stressor used (40 exercise, 349 dipyridamole and 111
dobutamine) was chosen on the basis of specific contra-
indications, local facilities and physician's preferences.
Pharmacological stress echocardiography was used when
patients were unable to exercise maximally, or when exercise
electrocardiography result was nondiagnostic or inconclu-
sive. Two-hundred forty seven (49%) patients were taking
antianginal medical therapy (β-blockers in 121, calcium-
antagonists in 113, and nitrates in 153) at the time of testing.
Diabetes [3], hypertension [4], and hypercholesterolemia
[5] were defined according to standard criteria. All
investigators of contributing centers passed quality control
criteria for regional wall motion prior to entering the study as
previously described [6].Data are entered in the data bank at
the time of testing on the same day of test performance.
Follow-up information on outcome is updated by a dedicated
team of technicians supervised by physicians not involved in
patient care. Physicians responsible for updating the follow-
up information were unaware of stress echo and coronary
angiography data.
2.2. Stress echocardiography
Exercise stress echo was conducted using a semi-supine
bicycle ergometer with 25 W incremental loading every
2 min. Dipyridamole (up to 0.84 mg over 10 min with co-
administration of atropine up to 1 mg, or up to 0.84 mg over
6 min) and dobutamine (up to 40 mg/kg/min with co-
administration of atropine up to 1 mg) stress echo were
performed according to the well-established protocols [7].
Echocardiographic images were semiquantitatively assessedPlease cite this article as: Cortigiani L, et al, Stress echocardiography for the risk
(2009), doi:10.1016/j.ijcard.2009.03.063using a 17 segments, 4-point scale model of the left ventricle
[8]. A wall motion score index (WMSI) was derived by
dividing the sum of individual segment scores by the number
of interpretable segments. Stress-induced ischemia was
defined as new or worsened wall motion abnormality or
biphasic response (i.e. low-dose improvement followed by
high-dose deterioration). Necrotic pattern was akinetic or
dyskinetic myocardium with no thickening during stress.
2.3. Outcome measures
Outcome was determined from patients' interview at the
outpatient clinic, hospital chart reviews and telephone
interviews, if necessary. The clinical events recorded during
the follow-up were death, myocardial infarction early
(b3 months) and late (N3 months) coronary revasculariza-
tion (surgery or angioplasty). Overall instead of cardiac
mortality was considered in order to avoid misclassification
of the death cause [9]. Only the first event was taken into
account for analysis. Myocardial infarction was defined
according to typical symptoms, electrocardiographic, and
cardiac enzyme changes. Follow-up data were separately
analyzed for the prediction of hard events (death, and
myocardial infarction), and major events (death, myocardial
infarction, and late revascularization).
2.4. Statistical analysis
Continuous and categorical variables are expressed as
mean±SD and percentage, respectively. Differences
between groups were compared using Student's t and chi-
square test, as appropriate. The association of selected
variables with outcome were assessed with the Cox's
proportional hazard model using univariate and stepwise
multivariate procedures. A significance of 0.05 was required
for a variable to be included into the multivariate model,
whilst 0.1 was the cut-off value for exclusion. Clinical,
resting echo and SE information were sequentially entered
into the model. A significant increase in global X2 of the
model after the addition of individual variables indicated an
incremental predictive value.
Survival rates were estimated with Kaplan–Meier curves
and compared by the log-rank test. Statistical significance
was set at pb0.05. Statistical Package for the Social Sciences
(SPSS release 15.0, Chicago, Illinois) was used for analysis.
3. Results
Baseline characteristics of the study population are
reported in Table 1.
Of the initial population, 52 patients were revascularized
within 3 months from the index test (8 surgery and 44 PCI).
Of them 36 (69%) had a positive test for myocardial ischemia.
During amedian follow-up of 25 (1st quartile 7, 3rd quartile
49) months, 61 patients died, 33 had a nonfatal myocardial
infarction, and 112 were revascularized at N3 months after thestratification of patients following coronary bypass surgery, Int J Cardiol
Table 1
Characteristics of the study population.
Age (years) 67±9
Males 400 (80%)
Prior myocardial infarction 316 (63%)
Left bundle branch block 23 (5%)
Diabetes mellitus 143 (29%)
Arterial hypertension 265 (53%)
Hypercholesterolemia 311 (62%)
Currently smokers 180 (36%)
β-blockers 121 (24%)
Calcium antagonists 113 (23%)
Nitrates 153 (31%)
At least one medication 247 (49%)
Resting wall motion score index 1.40±0.40
Resting wall motion abnormalities 363 (73%)
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(41%) major events. Among patients with stress-induced
ischemia, 48 hard (24%) and 78 (40%) major events were
observed.
Univariate and multivariate predictors of hard and major
events are reported in Table 2. After adjusting for the most
significant covariates, age and peak WMSI were indepen-
dent predictors of hard events. Same variables were
significant predictors of major events. Sequential inclusion
of rest and SE information significantly improved the
predictive value of the model (Fig. 1).
Survival analysis showed ischemia at SE to be associated
with significantly higher hard and major event rate (Fig. 2).
Ischemia at SE was similarly associated to higher rate of
major events in both symptomatic and asymptomatic
patients (Fig. 3).
4. Discussion
The results of the present study demonstrate that rest and
SE represent an effective tool for the risk stratification of
patients with previous CABG. In particular, the evidence ofTable 2
Univariate and multivariate predictors of hard and major events.
Hard events
Univariate analysis Multivariate analysi
HR (95% CI) p value HR (95% CI)
Age (years) 1.04 (1.01–1.06) 0.003 1.04 (1.02–1.07)
Gender (male) 1.69 (0.90–3.17) 0.10
Symptoms vs no symptom 1.18 (0.75–1.86) 0.47
Prior infarction 1.18 (0.75–1.85) 0.47
Diabetes mellitus 1.45 (0.93–2.25) 0.10
Arterial hypertension 1.28 (0.85–1.93) 0.24
Hypercholesterolemia 1.06 (0.70–1.61) 0.80
Smoking habit 1.12 (0.74–1.69) 0.59
Left bundle branch block 0.92 (0.33–2.55) 0.88
Resting WMSI 2.20 (1.39–3.46) 0.001
Therapy at the time of test 0.99 (0.66–1.49) 0.97
Peak WMSI 3.03 (1.93–4.77) b0.0001 3.07 (1.96–4.81)
HR=hazard ratio; CI=confidence interval.
Please cite this article as: Cortigiani L, et al, Stress echocardiography for the risk
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that provided by clinical data and resting echo. This
reinforces previous observations with exercise [10], dobu-
tamine [11], and dipyridamole [12] SE. Arruda et al. [10]
reported echocardiographically assessed exercise ejection
fraction and diabetes mellitus as independent predictors of
outcome in 718 patients undergoing CABG 5.7±4.7 years
before the index SE. Qualitatively assessed abnormal left
ventricular end-systolic volume response to exercise inde-
pendently predicted the combination of nonfatal myocardial
infarction and cardiac death, whilst workload was an
independent predictor of cardiac death. Though baseline
echocardiographic measurements were not fully detailed.
Authors acknowledged that the population studied was at
increased risk of cardiac events, as also demonstrated by the
inability to achieve maximal levels of exercise in 40% of
patients. Noteworthy, rest and peak exercise WMSI but not
exercise-induced ischemia were included as covariates in
multivariate analysis. Bountioukos et al. [11] reported
myocardial ischemia during dobutamine SE to be an
independent predictor of the combined endpoint of cardiac
death, nonfatal infarction and late revascularization in a
mixed group of 293 patients who previously underwent
either percutaneous or surgical coronary revascularization.
All patients included were unable to perform an exercise test
because of different prognostically relevant comorbidities.
Therefore, also this study dealt with a population at increased
risk of unfavourable outcome. More recently, Rossi et al.
[12] investigated the prognostic value of dipyridamole SE in
104 symptom-free patients with recent (b12 months)
complete revascularization either by CABG or percutaneous
coronary intervention. In this low-risk population, ischemia
at SE was a multivariable predictor of the composite end-
point of cardiac death and nonfatal acute coronary syndrome.
Differently, our patients were consecutively considered for
analysis independently of their risk profile and the stressor
used, thus making results more transferable to routine
clinical practice.Major events
s Univariate analysis Multivariate analysis
p value HR (95% CI) p value HR (95% CI) p value
0.002 1.02 (1.00–1.04) 0.05 1.03 (1.00–1.04) 0.02
1.63 (0.98–2.71) 0.06
1.24 (0.85–1.80) 0.26
1.00 (0.70–1.42) 1.00
1.43 (0.99–2.05) 0.05
1.10 (0.78–1.54) 0.58
0.95 (0.68–1.33) 0.77
1.32 (0.95–1.84) 0.10
1.06 (0.49–2.31) 0.88
1.81 (1.23–2.65) 0.002
0.98 (0.71–1.37) 0.93
b0.0001 2.39 (1.64–3.48) b0.0001 2.23 (1.52–3.28) b0.0001
stratification of patients following coronary bypass surgery, Int J Cardiol
Fig. 1. Incremental value of stress echocardiography (SE) in predicting cardiac hard and major events. The sequential addition of rest and SE to the clinical
information significantly increased the global chi-square of the predictive model.
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CABG patients is generally considered to depend upon the
presence or absence of symptoms and the time from the
surgical procedure. Although stress testing in patients with
chest pain is appropriate, and multiple major society
guidelines have argued against routine testing of all
asymptomatic patients after CABG [13–15], symptoms are
commonly atypical and cannot be considered as reliable
determinants of restenosis or graft occlusion. In keeping with
previous results with dobutamine SE [11], we found
recurrence of chest pain not to be associated with increased
risk of subsequent events at follow-up. Moreover, ischemia
at SE was equally effective in predicting an increase risk of
adverse outcome in symptomatic and asymptomatic patients.
On the other hand, significant reversible perfusion defects
suggestive of ischemia occur in about one-quarter of patients
by one year after CABG; not all of these patients have angina
[16,17]. Saphenous vein graft patency begins to decline
rapidly after five years, while patency rates for arterial grafts
remain high [18,19]. Stress perfusion imaging provided
important prognostic information in patients N5 years post-
CABG, irrespective of symptoms, and in symptomatic
patients who were ≤5 years post-CABG [16,17,20]. So
far, data have been more limited on the value of SE. TheFig. 2. Hard and major event rate curves according to the presence (
Please cite this article as: Cortigiani L, et al, Stress echocardiography for the risk
(2009), doi:10.1016/j.ijcard.2009.03.063results of our study confirm that, independently of the
stressor used, SE is an effective means of risk stratification at
a median time of N5 years in post-CABG patients with or
without ischemic symptoms and, therefore, it provides
guidance to appropriate management. Likely to those with
moderate to severe reversible perfusion defect on stress
nuclear perfusion imaging [21], patients with inducible
ischemia on SE should be considered for coronary
angiography.
4.1. Clinical implications
Recent guidelines on appropriateness criteria for stress
echocardiography released by the American College of
Cardiology Foundation and the American Society of
Echocardiography have identified (score=8, on a scale of
1 to 9) the execution of stress echo as “appropriate” in
symptomatic patients after CABG, not in the early post-
procedure period. Our results corroborate this indication,
since there was a clear added prognostic value of stress echo
in symptomatic patients after CABG [22].
The same guidelines consider stress echo “inappropriate”
(score=2) in asymptomatic patients less than 5 years after
CABG, and of “uncertain” appropriateness in asymptomatic+) or absence (−) of ischemia at stress echocardiography (SE).
stratification of patients following coronary bypass surgery, Int J Cardiol
Fig. 3. Major event rate curves in symptomatic and asymptomatic patients according to the presence (+) or absence (−) of ischemia at stress echocardiography
(SE).
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CABG. In this latter group, the score is 5 in patients who
were asymptomatic (e.g., silent ischemia) prior the previous
revascularization and 6 in patients who were symptomatic
prior to revascularization. In this diagnostic “gray zone”, we
certainly need more evidence. The results of the present
study document a clear added value of stress echo over
clinical and resting echo variables. This extra-value was high
in asymptomatic patients, and of the same order of
magnitude as in symptomatic patients. Interestingly, these
data are consistent with current practice in the real world. In a
comment released for Heartwire on appropriateness guide-
lines, a stress echo practitioner stated that “I also feel
strongly that periodic stress testing is helpful in patients who
required intervention despite the fact that their course was
asymptomatic until their heralding event. I would not feel
comfortable waiting five years post-CABG – as it is
recommended – in patients who have continued to smoke
or who have developed diabetes in the interim, for example”
[23]. The data of the present study may help to reconcile the
gap between current practice and guidelines recommenda-
tions, shifting the evidence in favour of an earlier and more
liberal approach to stress imaging, especially considering the
relatively low cost and lack of radiation exposure of stress
echo, impacting favorably on cost-benefit [24], risk-benefit
[25], and patient's acceptance [26], profile when compared
to myocardial perfusion imaging or cardio-CT [27].
4.2. Study limitations
Pooled results of exercise, dipyridamole and dobutamine
stress echo are presented. Although they can induce ischemia
by different mechanisms, their prognostic value [28–32] is
comparable when state of the art protocols are used. Due to
the long recruitment period, the outcome based on stress test
results may have been potentially influenced by evolution of
methodology, technology, expertise, advances in medical and
interventional treatments. In this study, there was no centralPlease cite this article as: Cortigiani L, et al, Stress echocardiography for the risk
(2009), doi:10.1016/j.ijcard.2009.03.063reading. Stress echocardiography was interpreted in the
peripheral centers and entered directly in the data bank. This
system allowed substantial sparing of human and technologic
resources but it was also the logical pre-requisite for a large
scale study, designed to represent the realistic performance of
the test rather than the results of a single lab – or even a single
person – working in a highly dedicated echo laboratory.
Because the assessment of the echocardiograms was
qualitative and subjective, variability in reading the echo-
cardiograms might have modulated the results of individual
centers. However, all our readers in individual centers had a
long lasting experience in echocardiography, and passed the
quality control in stress echo reading as previously
described [6]. Incomplete coronary revascularization may
have influenced stress test results and on its turn outcome for
the present patient population. However, we may assume the
number of incomplete revascularizations to be very small, if
not negligible.Acknowledgement
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